| 1 |
32743640 | Irinotecan and vandetanib create synergies for treatment of pancreatic cancer patients with concomitant TP53 and KRAS mutations. | 2021 May 20 |
2 |
| 2 |
28159923 | The anti-neoplastic activity of Vandetanib against high-risk medulloblastoma variants is profoundly enhanced by additional PI3K inhibition. | 2017 Jul 18 |
4 |
| 3 |
24138843 | Targeted therapy against EGFR and VEGFR using ZD6474 enhances the therapeutic potential of UV-B phototherapy in breast cancer cells. | 2013 Oct 20 |
1 |
| 4 |
20665703 | ZD6474 enhances paclitaxel antiproliferative and apoptotic effects in breast carcinoma cells. | 2011 Feb |
1 |